studies
liposomal
doxorubicin
Doxil
antineoplastic agent
platinum-resistant ovarian cancer
dose
toxicity
standard dosing regimen
weeks
severe
erythrodysesthesia
hand-foot syndrome
stomatitis
liposomal
doxorubicin
treatment regimen
document
level
activity
patient population
platinum/paclitaxel-refractory disease
